Therefore, LPS-mediated endotoxemia affects brain inflammation by enhancing the passage of circulating inflammatory cytokines across the blood–brain barrier, stimulating microglia via TLR4, and/or inhibiting vagal afferent neurons. The gene discussed is TLR4; the disease is serum lipopolysaccharide activity.